Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: Results from a randomized controlled study
✍ Scribed by Davis, John C. ;Revicki, Dennis ;van der Heijde, Désirée M. F. ;Rentz, Anne M. ;Wong, Robert L. ;Kupper, Hartmut ;Luo, Michelle P.
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 99 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To assess the impact of cyclophosphamide (CYC) on the health‐related quality of life (HRQOL) of patients with scleroderma after 12 months of treatment. ## Methods One hundred fifty‐eight subjects participated in the Scleroderma Lung Study, with 79 each randomized to CYC
## Abstract ## Objective To determine whether the effects of anti–tumor necrosis factor α (TNFα) in reducing the signs and symptoms of ankylosing spondylitis (AS) coincide with a reduction in spinal inflammation as detected by magnetic resonance imaging (MRI). ## Methods Pre‐ and postgadolinium